Medicine and Dentistry
Cohort Analysis
100%
Bloodstream Infection
36%
Lyme Neuroborreliosis
18%
Meningitis
18%
Nervous System Disorder
18%
Disease
18%
Infection
13%
Bacterial Meningitis
13%
Blood Culture
12%
Case-Control Study
11%
Borrelia burgdorferi
11%
Sequela
10%
Lyme Borreliosis
10%
Staphylococcus Aureus
10%
Borreliella
10%
Hazard Ratio
9%
Congestive Heart Failure
9%
Neuroborreliosis
9%
Intensive Care Unit
9%
Analgesic
9%
Diagnostic Accuracy
9%
Immunoglobulin M Antibody
9%
Borrelia
9%
Inflammatory Disorder
9%
Inflammatory Bowel Disease
9%
Bronchiectasis
9%
Cardiovascular Disease
9%
Pneumococcal Infection
9%
Chronic Obstructive Pulmonary Disease
9%
Pneumococcal Meningitis
9%
Attention Deficit Disorder
8%
Comorbidity
6%
Pneumococcus
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
54%
Bloodstream Infection
27%
Infection
21%
Chronic Obstructive Lung Disease
18%
Staphylococcus Aureus
13%
Lyme Disease
10%
SARS Coronavirus
9%
Observational Study
9%
Borreliella
9%
Prescription Drug
9%
Congestive Heart Failure
9%
Borrelia burgdorferi
9%
Stenotrophomonas maltophilia
9%
Infectious Agent
9%
Case Fatality Rate
9%
Meningitis
9%
Antibiotic Therapy
9%
Beta Hemolytic Streptococcus
9%
Bronchiectasis
9%
Cardiovascular Disease
9%
Pneumococcal Infection
9%
Escherichia coli
6%
Antiinfective Agent
5%
Respiratory Tract
5%
Nursing and Health Professions
Cohort Analysis
27%
Lyme Disease
18%
Bloodstream Infection
18%
Systematic Review
12%
Immunoglobulin M Antibody
9%
Antibiotic Therapy
9%
Meta Analysis
9%
Diagnostic Accuracy
9%
Intensive Care Unit
9%
Bronchiectasis
9%
Hospital Readmission
9%
Confidence Interval
7%